Progesterone treatment shows benefit in female rats in a pediatric model of controlled cortical impact injury

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Geddes, Rastafa I ^a   Peterson, Bethany L ^a   Stein, Donald G ^a   Sayeed, Iqbal ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE; GESTAGEN; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN INJURY; BRAIN LESION SIZE; CONTROLLED CORTICAL IMPACT INJURY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ELEVATED PLUS MAZE TEST; FEMALE; FRONTAL CORTEX; MEMORY; MORRIS WATER MAZE TEST; NERVOUS SYSTEM PARAMETERS; NONHUMAN; PEDIATRICS; RAT; ROTAROD TEST; SEX DIFFERENCE; SPATIAL ORIENTATION; ANIMAL; ANIMAL BEHAVIOR; BRAIN INJURIES; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; INJURIES; MALE; MAZE TEST; PATHOLOGY; PREFRONTAL CORTEX; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN INJURIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; PREFRONTAL CORTEX; PROGESTERONE; PROGESTINS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS;

EID: 84959243450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146419     Document Type: Article

References (81)

1. Coronado VG, McGuire LC, Sarmiento K, Bell J, Lionbarger MR, Jones CD, et al. Trends in Traumatic Brain Injury in the U.S. and the public health response: 1995-2009. J Safety Res. 2012; 43: 299-307. doi: 10.1016/j.jsr.2012.08.011 PMID: 23127680
2. Centers for Disease Control. Vital signs: avoidable deaths from heart disease, stroke, and hypertensive disease-United States, 2001-2010. MMWR Morbidity and mortality weekly report. 2013; 62: 721-727. PMID: 24005227
3. Loane DJ, Faden AI. Neuroprotection fortraumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci. 2010; 31: 596-604. doi: 10.1016/j.tips.2010.09.005 PMID: 21035878
4. Babikian T, Asarnow R. Neurocognitive outcomes and recovery after pediatric TBI: meta-analytic review of the literature. Neuropsychology. 2009; 23: 283-296. doi: 10.1037/a0015268 PMID: 19413443
5. Farrer TJ, Frost RB, Hedges DW. Prevalence of traumatic brain injury in juvenile offenders: a metaanalysis. Child Neuropsychol. 2013; 19: 225-234. doi: 10.1080/09297049.2011.647901 PMID: 22372420
6. Perron BE, Howard MO. Prevalence and correlates oftraumatic brain injury among delinquent youths. CrimBehav Ment Health. 2008; 18: 243-255. doi: 10.1002/cbm.702 PMID: 18803295
7. Williams WH, Cordan G, Mewse AJ, Tonks J, Burgess CN. Self-reported traumatic brain injury in male young offenders: a risk factor for re-offending, poor mental health and violence? Neuropsychol Rehabil. 2010; 20: 801-812. doi: 10.1080/09602011.2010.519613 PMID: 21069616
8. Kaore SN, Langade DK, Yadav VK, Sharma P, Thawani VR, Sharma R. Novel actions of progesterone: what we know today and what will be the scenario in the future? J Pharm Pharmacol. 2012; 64:1040-1062. doi: 10.1111/j.2042-7158.2012.01464.x PMID: 22775208
9. Luoma JI, Stern CM, Mermelstein PG. Progesterone inhibition of neuronal calcium signaling underlies aspects of progesterone-mediated neuroprotection. J Steroid Biochem Mol Biol. 2012; 131: 30-36. doi: 10.1016/j.jsbmb.2011.11.002 PMID: 22101209
10. Stein DG. Is progesterone a worthy candidate as a novel therapy for traumatic brain injury? Dialogues Clin Neurosci. 2011; 13: 352-359. PMID: 22033509
11. Coughlan T, Gibson C, Murphy S. Progesterone, BDNFand neuroprotection in the injured CNS. Int J Neurosci. 2009; 119:1718-1740. PMID: 19922383
12. Cai W, Zhu Y, Furuya K, Li Z, Sokabe M, Chen L. Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology. 2008; 55:127-138. doi: 10.1016/j.neuropharm.2008.04.023 PMID: 18572204
13. Singh M. Mechanisms of progesterone-induced neuroprotection. Ann NY Acad Sci. 2005; 1052:145-151. PMID: 16024757
14. Gonzalez Deniselle MC, Lopez Costa JJ, Gonzalez SL, Labombarda F, Garay L, Guennoun R, et al. Basis of progesterone protection in spinal cord neurodegeneration. J Steroid Biochem Mol Biol. 2002; 83:199-209. PMID: 12650717
15. Stein DG, Wright DW. Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin Investig Drugs. 2010; 19: 847-857. doi: 10.1517/13543784.2010.489549 PMID: 20486864
16. Li LM, Menon DK, Janowitz T. Cross-sectional analysis of data from the U.S. clinical trials database reveals poor translational clinical trial effort for traumatic brain injury, compared with stroke. PLoS One. 2014; 9: e84336. doi: 10.1371/journal.pone.0084336 PMID: 24416218
17. Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, et al. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med. 2014; 371: 2457-2466. doi: 10.1056/NEJMoa1404304 PMID: 25493974
18. Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, et al. A Clinical Trial of Progesterone for Severe Traumatic Brain Injury. N Engl J Med. 2014; 371: 2467-2476. doi: 10.1056/NEJMoa1411090 PMID: 25493978
19. Howard RB, Sayeed I, Stein D. Suboptimal dosing parameters as possible factors in the negative Phase III clinical trials of progesterone in TBI. J Neurotrauma. 2015. Sep 15. [Epub ahead of print]doi: 10.1089/neu.2015.4179
20. Stein DG. Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials. Brain Injury. 2015; 29:1259-1272. PMID: 26274493
21. Schumacher M, Denier C, Oudinet J-P, Adams DH, Guennoun R. Progesterone neuroprotection: The background of clinical trial failure. J Steroid Biochem Mol Biol. 2015 Nov 17. pii: S0960-0760(15)30135-7. doi: 10.1016/j.jsbmb.2015.11.010 [Epub ahead of print]
22. Peterson BL, Won S, Geddes RI, Sayeed I, Stein DG. Sex-related differences in effects of progesterone following neonatal hypoxic brain injury. Behav Brain Res. 2015; 286:152-165. doi: 10.1016/j.bbr. 2015.03.005 PMID: 25746450
23. Tucker LB, Fu AH, McCabe JT. Performance of male and female C57BL/6J Mice on motor and cognitive tasks commonly used in pre-clinical Traumatic Brain Injury research. J Neurotrauma. 2015 Aug 12. [Epub ahead of print] doi: 10.1089/neu.2015.3977
24. Wong R, Renton C, Gibson CL, Murphy SJ, Kendall DA, Bath PM, et al. Progesterone treatment for experimental stroke: an individual animal meta-analysis. J Cereb Blood Flow Metab. 2013; 33:1362-1372. doi: 10.1038/jcbfm.2013.120 PMID: 23838830
25. Robertson CL, Puskar A, Hoffman GE, Murphy AZ, Saraswati M, Fiskum G. Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats. Exp Neurol. 2006; 197: 235-243. PMID: 16259981
26. Geddes RI, Sribnick EA, Sayeed I, Stein DG. Progesterone treatment shows benefit in a pediatric model of moderate to severe bilateral brain injury. PLoS One. 2014; 9: e87252. doi: 10.1371/journal. pone.0087252 PMID: 24489882
27. Sengupta P. The laboratory rat: relating its age with human's. Int J PrevMed. 2013; 4: 624-630. PMID: 23930179
28. Goss CW, Hoffman SW, Stein DG. Behavioral effects and anatomic correlates after brain injury: a progesterone dose-response study. Pharmacol Biochem Behav. 2003; 76: 231-242. PMID: 14592674
29. Russell KL, Kutchko KM, Fowler SC, Berman NE, Levant B. Sensorimotor behavioral tests for use in a juvenile rat model of traumatic brain injury: assessment of sex differences. J Neurosci Methods. 2011; 199: 214-222. doi: 10.1016/j.jneumeth.2011.05.008 PMID: 21600923
30. Cutler SM, Pettus EH, Hoffman SW, Stein DG. Tapered progesterone withdrawal enhances behavioral and molecular recovery after traumatic brain injury. Exp Neurol. 2005; 195: 423-429. PMID: 16039652
31. Cutler SM, Vanlandingham JW, Stein DG. Tapered progesterone withdrawal promotes long-term recovery following brain trauma. Exp Neurol. 2006; 200: 378-385. PMID: 16797538
32. Farace E, Alves WM. Do women fare worse: a metaanalysis of gender differences in traumatic brain injury outcome. J Neurosurg. 2000; 93: 539-545. PMID: 11014529
33. Morrison WE, Arbelaez JJ, Fackler JC, De Maio A, Paidas CN. Gender and age effects on outcome after pediatric traumatic brain injury. PediatrCrit Care Med. 2004; 5:145-151. PMID: 14987344
34. Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC, et al. ProTECT: A randomized clinical trial of progesterone for acute Traumatic Brain Injury. Ann Emerg Med. 2007; 49 391-402 PMID: 17011666
35. Ratcliff JJ, Greenspan AI, Goldstein FC, Stringer AY, Bushnik T, Hammond FM, et al. Gender and traumatic brain injury: do the sexes fare differently? Brain Inj. 2007; 21:1023-1030. PMID: 17891564
36. Gibson CL, Gray LJ, Bath PM, Murphy SP. Progesterone for the treatment of experimental brain injury; asystematic review. Brain. 2008; 131: 318-328. PMID: 17715141
37. Davis DP, Douglas DJ, Smith W, Sise MJ, Vilke GM, Holbrook TL, et al. Traumatic brain injury outcomes in pre- and post- menopausal females versus age-matched males. J Neurotrauma. 2006; 23: 140-148. PMID: 16503798
38. Stein DG, Hoffman SW. Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr Rehabil. 2003; 6:13-22. PMID: 12745891
39. Roof RL, Hall ED. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma. 2000; 17: 367-388. PMID: 10833057
40. Roof RL, Hall ED. Estrogen-related gender difference in survival rate and cortical blood flow after impact-acceleration head injury in rats. J Neurotrauma. 2000; 17:1155-1169. PMID: 11186229
41. Bazarian JJ, Blyth B, Mookerjee S, He H, McDermott MP. Sex differences in outcome after mild traumatic brain injury. J Neurotrauma. 2010; 27: 527-539. doi: 10.1089/neu.2009.1068 PMID: 19938945
42. Yeung JH, Mikocka-Walus AA, Cameron PA, Poon WS, Ho HF, Chang A, et al. Protection from traumatic brain injury in hormonally active women vs men of a similar age: a retrospective international study. Arch Surg. 2011; 146: 436-442. doi: 10.1001/archsurg.2011.46 PMID: 21502452
43. Ma J, Huang S, Qin S, You C. Progesterone for acute traumatic brain injury. Cochrane Database Syst Rev. 2012; 10: CD008409. doi: 10.1002/14651858.CD008409.pub3 PMID: 23076947
44. Wright DW, Stein DG, Sayeed I, Hua F, Atif F, Yousuf S, et al. Response to: Do pregnant women have improved outcomes aftertraumatic brain injury? Am J Surg. 2012; 204: 803-804. doi: 10.1016/j. amjsurg.2011.05.002 PMID: 21880296
45. Berry C, Mirocha J, Salim A. Response to: Do pregnant women have improved outcomes aftertraumatic brain injury. Am J Surg. 2012; 204: 558-560.
46. Wagner AK, McCullough EH, Niyonkuru C, Ozawa H, Loucks TL, Dobos JA, et al. Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury. J Neurotrauma. 2011; 28: 871-888. doi: 10.1089/neu.2010.1586 PMID: 21488721
47. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ 3rd, Spack NP, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009; 94: 3132-3154. doi: 10.1210/jc.2009-0345 PMID: 19509099
48. Haider AH, Efron DT, Haut ER, Chang DC, Paidas CN, Cornwell EE3rd. Mortality in adolescent girls vs boys following traumatic shock: an analysis of the National Pediatric Trauma Registry. Arch Surg. 2007; 142: 875-880; discussion 879-880. PMID: 17875843
49. Ley EJ, Short SS, Liou DZ, Singer MB, Mirocha J, Melo N, et al. Gender impacts mortality after traumatic brain injury in teenagers. J Trauma Acute Care Surg. 2013; 75: 682-686. doi: 10.1097/TA. 0b013e31829d024f PMID: 24064883
50. Holmes GL, Weber DA. The effect of progesterone on kindling: a developmental study. Brain Res. 1984; 318: 45-53. PMID: 6488053
51. Frye CA. Progesterone reduces depressive behavior of young ovariectomized, aged progestin receptor knockout, and aged wild type mice in the tail suspension test. J Psychopharmacol. 2011; 25: 421-428. doi: 10.1177/0269881109349836 PMID: 19965943
52. Tsuji M, Taguchi A, Ohshima M, Kasahara Y, Ikeda T. Progesterone and allopregnanolone exacerbate hypoxic-ischemic brain injury in immature rats. Exp Neurol. 2012; 233: 214-220. doi: 10.1016/j. expneurol.2011.10.004 PMID: 22020180
53. Uysal N, Baykara B, Kiray M, Cetin F, Aksu I, Dayi A, et al. Combined treatment with progesterone and magnesium sulfate positively affects traumatic brain injury in immature rats. Turk Neurosurg. 2013; 23: 129-137. doi: 10.5137/1019-5149.JTN.5582-11.1 PMID: 23546895
54. Robertson CL, Saraswati M. Progesterone protects mitochondrial function in a rat model of pediatric traumatic brain injury. J Bioenerg Biomembr. 2014.
55. Hill CA, Fitch RH. Sex differences in mechanisms and outcome of neonatal hypoxia-ischemia in rodent models: implications for sex-specific neuroprotection in clinical neonatal practice. Neurol Res Int. 2012; 2012: 867531. doi: 10.1155/2012/867531 PMID: 22474588
56. Mannix R, Berglass J, Berkner J, Moleus P, Qiu J, Jantzie LL, et al. Sex differences in the effect of progesterone after controlled cortical impact in adolescent mice: a preliminary study. J Neurosurg. 2014; 121:1337-1341. doi: 10.3171/2014.8.JNS14715 PMID: 25280093
57. Rogol AD, Roemmich JN, Clark PA. Growth at puberty. J Adolesc Health. 2002; 31:192-200. PMID: 12470915
58. Attella MJ, Nattinville A, Stein DG. Hormonal state affects recovery from frontal cortex lesions in adult female rats. Behav Neural Biol. 1987; 48: 352-367. PMID: 3689284
59. Roof RL, Zhang Q, Glasier MM, Stein DG. Gender-specific impairment on Morris water maze task after entorhinal cortex lesion. Behav Brain Res. 1993; 57: 47-51. PMID: 8292254
60. Roof RL, Duvdevani R, Stein DG. Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res. 1993; 607: 333-336. PMID: 8481809
61. Bramlett HM, Dietrich WD. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab. 2004; 24:133-150. PMID: 14747740
62. Kolb B, Cioe J. Recovery from early cortical damage in rats, VIII. Earlier may be worse: behavioural dysfunction and abnormal cerebral morphogenesis following perinatal frontal cortical lesions in the rat. Neuropharmacology. 2000; 39: 756-764. PMID: 10699442
63. Hamm RJ, Pike BR, O'Dell DM, Lyeth BG, Jenkins LW. The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J Neurotrauma. 1994; 11:187-196. PMID: 7932797
64. Adelson PD, Skinner JC, Davis DS, Tran MP, Dixon CE, Kochanek PM, et al. A model of focal TBI in the neonatal rat. J Neurotrauma. 2000; 17: 929.
65. Wagner AK, Willard LA, Kline AE, Wenger MK, Bolinger BD, Ren D, et al. Evaluation of estrous cycle stage and gender on behavioral outcome after experimental traumatic brain injury. Brain Res. 2004; 998:113-121. PMID: 14725974
66. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985; 14:149-167. PMID: 2864480
67. Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003; 463: 3-33. PMID: 12600700
68. Parker V, Morinan A. The socially isolated rat as a model for anxiety. Neuropharmacology. 1986; 25: 663-664.
69. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984; 11: 47-60. PMID: 6471907
70. Newhouse P, Newhouse C, Astur RS. Sex differences in visual-spatial learning using a virtual water maze in pre-pubertal children. Behav Brain Res. 2007; 183:1-7. PMID: 17629971
71. Kallai J, Makany T, Karadi K, Jacobs WJ. Spatial orientation strategies in Morris-type virtual water task for humans. Behav Brain Res. 2005; 159:187-196. PMID: 15817182
72. Astur RS, Tropp J, Sava S, Constable RT, Markus EJ. Sex differences and correlations in a virtual Morris water task, a virtual radial arm maze, and mental rotation. Behav Brain Res. 2004; 151:103-115. PMID: 15084426
73. Mueller SC, Temple V, Cornwell B, Grillon C, Pine DS, Ernst M. Impaired spatial navigation in pediatric anxiety. J Child Psychol Psychiatry. 2009; 50:1227-1234. doi: 10.1111/j.1469-7610.2009.02112.x PMID: 19594834
74. Lacroix L, White I, Feldon J. Effect of excitotoxic lesions of rat medial prefrontal cortex on spatial memory. Behav Brain Res. 2002; 133: 69-81. PMID: 12048175
75. Hull EM. Effects of neonatal exposure to progesterone in sexual behavior of male and female rats. Physiol Behav. 1981; 26: 401-405. PMID: 7243957
76. Reddy DS, Gangisetty O, Briyal S. Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis. Neuropharmacology. 2010; 59: 573-581. doi: 10.1016/j.neuropharm. 2010.08.017 PMID: 20804775
77. Dableh LJ, Henry JL. Progesterone prevents development of neuropathic pain in a rat model: Timing and duration of treatment are critical. J Pain Res. 2011; 4: 91-101. doi: 10.2147/JPR.S17009 PMID: 21559355
78. Adelson PD, Fellows-Mayle W, Kochanek PM, Dixon CE. Morris water maze function and histologic characterization of two age-at-injury experimental models of controlled cortical impact in the immature rat. Childs Nerv Syst. 2013; 29: 43-53. doi: 10.1007/s00381-012-1932-4 PMID: 23089934
79. Kolb B, Mychasiuk R, Muhammad A, Gibb R. Brain plasticity in the developing brain. Prog Brain Res. 2013; 207: 35-64. doi: 10.1016/B978-0-444-63327-9.00005-9 PMID: 24309250
80. Halliwell C, Comeau W, Gibb R, Frost DO, Kolb B. Factors influencing frontal cortex development and recovery from early frontal injury. Dev Neurorehabil. 2009; 12: 269-278. doi: 10.3109/17518420903087715 PMID: 20477557
81. Kolb B, Mychasiuk R, Williams P, Gibb R. Brain plasticity and recovery from early cortical injury. Dev Med Child Neurol. 2011; 53 Suppl 4: 4-8. doi: 10.1111/j.1469-8749.2011.04054.x PMID: 21950386